About Skysis
Skysis is a company based in Scottsdale (United States) founded in 2011 by Jeff Martini, Norman Stalsberg, and Dan Twibell was acquired by Fishawack in April 2020. Skysis offers products and services including Marketing Consulting, Medical Policy Consulting, Evidence Consulting, and Data and Technology Consulting. Skysis operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
- Headquarter Scottsdale, United States
- Founders Jeff Martini, Norman Stalsberg, Dan Twibell
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Skysis
Skysis offers a comprehensive portfolio of products and services, including Marketing Consulting, Medical Policy Consulting, Evidence Consulting, and Data and Technology Consulting.
Provides strategies for healthcare marketing and promotion.
Offers advice on medical policy and access development.
Delivers value and evidence-based healthcare consulting.
Focuses on data management and media technology solutions.
Funding Insights of Skysis
Detailed funding history for Skysis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Skysis
Skysis has secured backing from 1 investor. Prominent investors backing the company include Fishawack.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
Locked | Locked | Locked |
Investor details for Skysis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Skysis
Investment portfolio details for Skysis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Skysis
Detailed financials for Skysis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Skysis Comparisons
Peer comparison for Skysis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Skysis
Skysis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
Detailed competitors of Skysis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Skysis
Complete news archive for Skysis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Skysis
Skysis was founded in 2011.
Skysis is headquartered in Scottsdale, United States. It is registered at Scottsdale, Arizona, United States.
Skysis was established in 2011 in Scottsdale, United States, as a provider of consulting services within the biopharma sector. Advisory support is offered to biopharmaceutical firms on operational and strategic matters. The company is directed by co-founders Jeff Martini and Dan Twibell, with Norman Stalsberg as founder. Focus is placed on tailored solutions for drug development and regulatory challenges in the North American market.
Skysis's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Skysis offers Marketing Consulting, Medical Policy Consulting, Evidence Consulting, and Data and Technology Consulting.
Skysis has 1 investor. Key investors include Fishawack.